Skip to main content
. 2022 Mar 25;5(2):261–270. doi: 10.20517/cdr.2021.100

Figure 5.

Figure 5

Prognostic analysis of miR-30-5p, and SOX4 mRNA expression in 120 non-small cell lung cancer (NSCLC) patients. (A and B) Prognostic analysis of miR-30-5p expression in 120 NSCLC patients; (C and D) Prognostic analysis of SOX4 mRNA expression in 120 NSCLC patients.